Production of pigs transgenic for human DAF to overcome complement-mediated hyperacute xenograft rejection in man
- 31 December 1996
- journal article
- review article
- Published by Elsevier in Research in Immunology
- Vol. 147 (2) , 88-94
- https://doi.org/10.1016/0923-2494(96)87179-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The generation of transgenic pigs as potential organ donors for humansNature Medicine, 1995
- Human complement regulatory proteins protect swine-to-primate cardiac xenografts from humoral injuryNature Medicine, 1995
- TISSUE EXPRESSION OF HUMAN COMPLEMENT INHIBITOR, DECAY-ACCELERATING FACTOR, IN TRANSGENIC PIGS A POTENTIAL APPROACH FOR PREVENTING XENOGRAFT REJECTIONTransplantation, 1995
- Membrane cofactor protein (CD46) protects cells from complement-mediated attack by an intrinsic mechanism.The Journal of Experimental Medicine, 1992
- Discordant xenografting: challenges and controversiesCurrent Opinion in Immunology, 1991
- Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage.The Journal of Experimental Medicine, 1991
- Transfection of human CD59 complementary DNA into rat cells confers resistance to human complementEuropean Journal of Immunology, 1991
- Genetic Engineering of LivestockScience, 1989
- Separation of self from non-self in the complement systemImmunology Today, 1987
- Isolation of biologically active ribonucleic acid from sources enriched in ribonucleaseBiochemistry, 1979